EquityFlowCompanies › UroMems

UroMems

Healthtech · Grenoble, FR

Develops UroActive, the first automated artificial urinary sphincter implant for stress urinary incontinence.

Funding history

DateRoundAmount
May 2026Funding round
UroMems (Grenoble) secured a $60M strategic investment from Ajax Health, its largest round, for pivotal clinical trials of the UroActive implant in the US and France.
$60M

Investors

Ajax Health

Similar companies in Healthtech

Explore funding flow on EquityFlow →